A solution of 2-hydrazine pyridine (504 mg, 4.62 mmol) in water (8 mL) was dropwise added
Both oral administration in drinking water and intraperitoneal injection produced significant pressure increases, though direct gastric application showed effects within minutes

coadministration of weight-based RBV is recommended if testing for Y93H is positive.[12] Additionally, the American Association for the Study of Liver Diseases recommends 12 weeks of SOF/VEL plus RBV, regardless of viral resistance testing, for prior pegIFN/RBV treatment-experienced patients with compensated cirrhosis, in part based on a modest increase in SVR12 rate observed with RBV coadministration in patients with cirrhosis and prior IFN-based treatment experience.[15] The European Association for the Study of the Liver recommends that patients with compensated cirrhosis and/or prior treatment experience who test positive for Y93H in nonstructural protein 5A (NS5A) should also have weight-based RBV coadministered with SOF/VEL.[13] Most recently the American Association for the Study of Liver Diseases recommended 12 weeks of glecaprevir/pibrentasvir for treatment-naive patients with GT3 infection and compensated cirrhosis, without the need for viral resistance testing or RBV coadministration

[4] [6] Ascorbic Acid (Vitamin C) Injection is contraindicated in individuals with a known hypersensitivity to ascorbic acid or any component of the formulation
Jain et al., 2020)
This helps in illness prevention, muscle recovery, and healthier skin, nails, and hair